Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial

ClinicalTrials.gov identifier (NCT number): NCT03852537, Registered February 25, 2019.

Detalles Bibliográficos
Autores principales: Odeyemi, Yewande E., Chalmers, Sarah J., Barreto, Erin F., Jentzer, Jacob C., Gajic, Ognjen, Yadav, Hemang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724733/
https://www.ncbi.nlm.nih.gov/pubmed/34983600
http://dx.doi.org/10.1186/s13054-021-03873-2
_version_ 1784625971576438784
author Odeyemi, Yewande E.
Chalmers, Sarah J.
Barreto, Erin F.
Jentzer, Jacob C.
Gajic, Ognjen
Yadav, Hemang
author_facet Odeyemi, Yewande E.
Chalmers, Sarah J.
Barreto, Erin F.
Jentzer, Jacob C.
Gajic, Ognjen
Yadav, Hemang
author_sort Odeyemi, Yewande E.
collection PubMed
description ClinicalTrials.gov identifier (NCT number): NCT03852537, Registered February 25, 2019.
format Online
Article
Text
id pubmed-8724733
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87247332022-01-04 Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial Odeyemi, Yewande E. Chalmers, Sarah J. Barreto, Erin F. Jentzer, Jacob C. Gajic, Ognjen Yadav, Hemang Crit Care Research Letter ClinicalTrials.gov identifier (NCT number): NCT03852537, Registered February 25, 2019. BioMed Central 2022-01-04 /pmc/articles/PMC8724733/ /pubmed/34983600 http://dx.doi.org/10.1186/s13054-021-03873-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Letter
Odeyemi, Yewande E.
Chalmers, Sarah J.
Barreto, Erin F.
Jentzer, Jacob C.
Gajic, Ognjen
Yadav, Hemang
Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial
title Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial
title_full Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial
title_fullStr Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial
title_full_unstemmed Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial
title_short Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial
title_sort early, biomarker-guided steroid dosing in covid-19 pneumonia: a pilot randomized controlled trial
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724733/
https://www.ncbi.nlm.nih.gov/pubmed/34983600
http://dx.doi.org/10.1186/s13054-021-03873-2
work_keys_str_mv AT odeyemiyewandee earlybiomarkerguidedsteroiddosingincovid19pneumoniaapilotrandomizedcontrolledtrial
AT chalmerssarahj earlybiomarkerguidedsteroiddosingincovid19pneumoniaapilotrandomizedcontrolledtrial
AT barretoerinf earlybiomarkerguidedsteroiddosingincovid19pneumoniaapilotrandomizedcontrolledtrial
AT jentzerjacobc earlybiomarkerguidedsteroiddosingincovid19pneumoniaapilotrandomizedcontrolledtrial
AT gajicognjen earlybiomarkerguidedsteroiddosingincovid19pneumoniaapilotrandomizedcontrolledtrial
AT yadavhemang earlybiomarkerguidedsteroiddosingincovid19pneumoniaapilotrandomizedcontrolledtrial

Ejemplares similares